Fatal varicella due to the vaccine-strain varicella-zoster virus

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 1, 2014, Pages 146-149

  Leung, Jessica ^a   Siegel, Subhadra ^b   Jones, James F ^c   Schulte, Cynthia ^d   Blog, Debra ^d   Schmid, D Scott ^a   Bialek, Stephanie R ^a   Marin, Mona ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^d NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

Author keywords

Acyclovir resistance; Vaccine adverse event; Vaccine strain; Varicella; Varicella zoster virus; VZV

Indexed keywords

ACICLOVIR; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BUDESONIDE; CHICKENPOX VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MEASLES VACCINE; METHYLPREDNISOLONE; MUMPS VACCINE; PNEUMOCOCCUS VACCINE; PREDNISOLONE; PREDNISONE; RUBELLA VACCINE; SALBUTAMOL;

ARTICLE; CASE REPORT; CAUSE OF DEATH; CHICKENPOX; CHILD; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG FATALITY; FAILURE TO THRIVE; FEMALE; HAEMOPHILUS INFECTION; HOSPITAL READMISSION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LOW DRUG DOSE; MEASLES; MULTIPLE ORGAN FAILURE; MUMPS; NONHUMAN; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; RASH; RECURRENT DISEASE; RESPIRATORY DISTRESS; RESPIRATORY TRACT DISEASE; RUBELLA; SEPSIS; SKIN DEFECT; TRACHEOBRONCHIAL TOILET; VACCINATION; VARICELLA ZOSTER VIRUS; VIRUS DETECTION; VIRUS STRAIN;

EID: 84896727002     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.26200     Document Type: Article

References (33)

1. Lopez AS, Zhang J, Brown C, Bialek S. Varicella-related hospitalizations in the United States, 2000-2006: the 1-dose varicella vaccination era. Pediatrics 2011; 127:238-45; PMID:21199857; http://dx.doi.org/10.1542/peds.2010- 0962
2. Marin M, Zhang JX, Seward JF. Near elimination of varicella deaths in the US after implementation of the vaccination program. Pediatrics 2011; 128:214-20; PMID:21788222; http://dx.doi.org/10.1542/peds.2010-3385
3. Chaves SS, Haber P, Walton K, Wise RP, Izurieta HS, Schmid DS, Seward JF. Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005. J Infect Dis 2008; 197(Suppl 2):S170-7; PMID:18419393; http://dx.doi.org/10.1086/522161
4. Jean-Philippe P, Freedman A, Chang MW, Steinberg SP, Gershon AA, LaRussa PS, Borkowsky W. Severe varicella caused by varicella-vaccine strain in a child with significant T-cell dysfunction. Pediatrics 2007; 120:e1345-9; PMID:17974726; http://dx.doi.org/10.1542/peds.2004-1681
5. Marin M, Güris D, Chaves SS, Schmid S, Seward JF; Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56(RR-4):1-40; PMID:17585291
6. Willis ED, Sweet A, Lievano F, Nicholson O, Dana A. Reported adverse experiences in patients with unknown immunosuppressive conditions vaccinated with Varivax. In: Program and abstracts of the 47th annual meeting of the Infectious Diseases Society of America (Philadelphia, PA). Arlington, VA: Infectious Diseases Society of America, 2009:1176.
7. Banovic T, Yanilla M, Simmons R, Robertson I, Schroder WA, Raffelt NC, Wilson YA, Hill GR, Hogan P, Nourse CB. Disseminated varicella infection caused by varicella vaccine strain in a child with low invariant natural killer T cells and diminished CD1d expression. J Infect Dis 2011; 204:1893-901; PMID:22043019; http://dx.doi.org/10.1093/infdis/jir660
8. Bryan CJ, Prichard MN, Daily S, Jefferson G, Hartline C, Cassady KA, Hilliard L, Shimamura M. Acyclovir-resistant chronic verrucous vaccine strain varicella in a patient with neuroblastoma. Pediatr Infect Dis J 2008; 27:946-8; PMID:18776818; http://dx.doi.org/10.1097/INF.0b013e318175d85c
9. Galea SA, Sweet A, Beninger P, Steinberg SP, Larussa PS, Gershon AA, Sharrar RG. The safety profile of varicella vaccine: a 10-year review. J Infect Dis 2008; 197(Suppl 2):S165-9; PMID:18419392; http://dx.doi.org/10.1086/522125
10. Ghaffar F, Carrick K, Rogers BB, Margraf LR, Krisher K, Ramilo O. Disseminated infection with varicella-zoster virus vaccine strain presenting as hepatitis in a child with adenosine deaminase deficiency. Pediatr Infect Dis J 2000; 19:764-6; PMID:10959752; http://dx.doi.org/10.1097/00006454-200008000- 00022
11. Kramer JM, LaRussa P, Tsai WC, Carney P, Leber SM, Gahagan S, Steinberg S, Blackwood RA. Disseminated vaccine strain varicella as the acquired immunodeficiency syndrome-defining illness in a previously undiagnosed child. Pediatrics 2001; 108:E39; PMID:11483849; http://dx.doi.org/10.1542/peds.108.2. e39
12. Levin MJ, Dahl KM, Weinberg A, Giller R, Patel A, Krause PR. Development of resistance to acyclovir during chronic infection with the Oka vaccine strain of varicella-zoster virus, in an immunosuppressed child. J Infect Dis 2003; 188:954-9; PMID:14513413; http://dx.doi.org/10.1086/378502
13. Levy O, Orange JS, Hibberd P, Steinberg S, LaRussa P, Weinberg A, Wilson SB, Shaulov A, Fleisher G, Geha RS, et al. Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells. J Infect Dis 2003; 188:948-53; PMID:14513412; http://dx.doi.org/10.1086/378503
14. Schrauder A, Henke-Gendo C, Seidemann K, Sasse M, Cario G, Moericke A, Schrappe M, Heim A, Wessel A. Varicella vaccination in a child with acute lymphoblastic leukaemia. Lancet 2007; 369:1232; PMID:17416267; http://dx.doi.org/10.1016/S0140-6736(07)60567-4
15. Sharrar RG, LaRussa P, Galea SA, Steinberg SP, Sweet AR, Keatley RM, Wells ME, Stephenson WP, Gershon AA. The postmarketing safety profile of varicella vaccine. Vaccine 2000; 19:916-23; PMID:11115716; http://dx.doi.org/10. 1016/S0264-410X(00)00297-8
16. Wise RP, Salive ME, Braun MM, Mootrey GT, Seward JF, Rider LG, Krause PR. Postlicensure safety surveillance for varicella vaccine. JAMA 2000; 284:1271-9; PMID:10979114; http://dx.doi.org/10.1001/jama.284.10.1271
17. Kim W. Immunology and Allergy. In: Johns Hopkins Hospital, Arcara K, Tschudy M, eds. The Harriet Lane Handbook. Philadelphia, PA: Elsevier Mosby, 2011:354-69.
18. Lev A, Simon AJ, Broides A, Levi J, Garty BZ, Rosenthal E, Amariglio N, Rechavi G, Somech R. Thymic function in MHC class II-deficient patients. J Allergy Clin Immunol 2013; 131:831-9; PMID:23228244; http://dx.doi.org/10.1016/ j.jaci.2012.10.040
19. Keusch GT. Nutritional effects on response of children in developing countries to respiratory tract pathogens: implications for vaccine development. Rev Infect Dis 1991; 13(Suppl 6):S486-91; PMID:1907399; http://dx.doi.org/10. 1093/clinids/13.Supplement-6.S486
20. Lopez AS, Burnett-Hartman A, Nambiar R, Ritz L, Owens P, Loparev VN, Guris D, Schmid DS. Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004. J Infect Dis 2008; 197:646-53; PMID:18260757; http://dx.doi.org/10.1086/527419
21. American Academy of Pediatrics. Varicella-Zoster Infections. In: Pickering LK, ed. Red Book: 2012 Report of the Committee on Infectious Diseases Elk Grove Village, IL: American Academy Pediatrics, 2012:774-89.
22. National Center for Immunization and Respiratory Diseases. General recommendations on immunization - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011; 60:1-64; PMID:21293327
23. Silk HJ, Guay-Woodford L, Perez-Atayde AR, Geha RS, Broff MD. Fatal varicella in steroid-dependent asthma. J Allergy Clin Immunol 1988; 81:47-51; PMID:3339190; http://dx.doi.org/10.1016/0091-6749(88)90219-9
24. Lydick E, Kuter BJ, Zajac BA, Guess HA; NIAID Varicella Vaccine Collaborative Study Group. Association of steroid therapy with vaccine-associated rashes in children with acute lymphocytic leukaemia who received Oka/Merck varicella vaccine. Vaccine 1989; 7:549-53; PMID:2558454; http://dx.doi.org/10.1016/0264-410X(89)90281-8
25. Gershon A, Takahashi M, Seward JF. Varicella vaccine. In: Plotkin S, Orenstein W, Offit P, eds. Vaccines: Saunders Elsevier, 2008:915-58.
26. Crassard N, Souillet AL, Morfin F, Thouvenot D, Claudy A, Bertrand Y. Acyclovir-resistant varicella infection with atypical lesions in a non-HIV leukemic infant. Acta Paediatr 2000; 89:1497-9; PMID:11195245; http://dx.doi.org/10.1111/j.1651-2227.2000.tb02785.x
27. Pahwa S, Biron K, Lim W, Swenson P, Kaplan MH, Sadick N, Pahwa R. Continuous varicella-zoster infection associated with acyclovir resistance in a child with AIDS. JAMA 1988; 260:2879-82; PMID:3184352; http://dx.doi.org/10. 1001/jama.1988.03410190127035
28. Saint-Léger E, Caumes E, Breton G, Douard D, Saiag P, Huraux JM, Bricaire F, Agut H, Fillet AM. Clinical and virologic characterization of acyclovir-resistant varicella-zoster viruses isolated from 11 patients with acquired immunodeficiency syndrome. Clin Infect Dis 2001; 33:2061-7; PMID:11702291; http://dx.doi.org/10.1086/324503
29. Wauters O, Lebas E, Nikkels AF. Chronic mucocutaneous herpes simplex virus and varicella zoster virus infections. J Am Acad Dermatol 2012; 66:e217-27; PMID:21056516; http://dx.doi.org/10.1016/j.jaad.2010.07.011
30. Shiraki K, Matsui S, Aiba N. Susceptibility of Oka varicella vaccine strain to antiviral drugs. Vaccine 1993; 11:1380-2; PMID:8310756; http://dx.doi.org/10.1016/0264-410X(93)90164-S
31. Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H; Centers for Disease Control and Prevention (CDC); National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009; 58(RR-4):1-207, quiz CE1-4; PMID:19357635
32. Mofenson LM, Brady MT, Danner SP, Dominguez KL, Hazra R, Handelsman E, Havens P, Nesheim S, Read JS, Serchuck L, et al.; Centers for Disease Control and Prevention; National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America; Pediatric Infectious Diseases Society; American Academy of Pediatrics. Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. MMWR Recomm Rep 2009; 58(RR-11):1-166; PMID:19730409
33. Gershon AA. Varicella vaccine: rare serious problems - but the benefits still outweigh the risks. J Infect Dis 2003; 188:945-7; PMID:14513411; http://dx.doi.org/10.1086/378504